MicroStrategy
MSTR
NVIDIA
NVDA
Adobe
ADBE
Salesforce
CRM
Apple
AAPL
US Stock MarketDetailed Quotes
ZNTL Zentalis Pharmaceuticals
- 3.000
- +0.070+2.39%
Close Dec 20 16:00 ET
- 3.000
- 0.0000.00%
Post 20:01 ET
213.80MMarket Cap-1.20P/E (TTM)
3.100High2.890Low1.85MVolume2.900Open2.930Pre Close5.57MTurnover3.59%Turnover RatioLossP/E (Static)71.27MShares18.07052wk High0.60P/B154.86MFloat Cap2.66052wk Low--Dividend TTM51.62MShs Float87.190Historical High--Div YieldTTM7.17%Amplitude2.660Historical Low3.006Avg Price1Lot Size
Zentalis Pharmaceuticals Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 40.56M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --40.56M | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | -17.99%51.43M | 11.65%65.15M | 0.57%65.33M | 11.73%253.94M | 31.24%67.92M | 15.73%62.72M | -8.06%58.35M | 12.22%64.95M | 4.96%227.29M | 7.39%51.75M |
| Selling and administrative expenses | -8.43%14.61M | 7.01%16.76M | -3.84%15.74M | 17.96%64.35M | 46.93%16.37M | 32.81%15.95M | -20.23%15.66M | 39.11%16.37M | 33.25%54.55M | 14.19%11.14M |
| -General and administrative expense | -8.43%14.61M | 7.01%16.76M | -3.84%15.74M | 17.96%64.35M | 46.93%16.37M | 32.81%15.95M | -20.23%15.66M | 39.11%16.37M | 33.25%54.55M | 14.19%11.14M |
| Research and development costs | -21.26%36.82M | 13.36%48.39M | 2.06%49.59M | 9.76%189.59M | 26.94%51.56M | 10.87%46.77M | -2.60%42.68M | 5.36%48.58M | -1.63%172.73M | 5.66%40.62M |
| Operating profit | 17.99%-51.43M | -11.65%-65.15M | 61.87%-24.77M | -11.73%-253.94M | -31.24%-67.92M | -15.73%-62.72M | 8.06%-58.35M | -12.22%-64.95M | -4.96%-227.29M | -7.39%-51.75M |
| Net non-operating interest income expense | ||||||||||
| Other net income (expense) | 56.01%11.25M | 44.40%-22.86M | 750.52%34.95M | -483.35%-22.95M | 111.88%6.85M | 278.43%7.21M | -9,797.41%-41.12M | 864.55%4.11M | -88.48%5.99M | 3,572.73%3.23M |
| Gain on sale of security | 56.01%11.25M | -613.66%-22.86M | 750.52%34.95M | 277.77%22.62M | 111.88%6.85M | 278.43%7.21M | 949.76%4.45M | 864.55%4.11M | 1,393.02%5.99M | 3,572.73%3.23M |
| Special income (charges) | --0 | --0 | ---- | ---45.57M | --0 | --0 | ---45.57M | ---- | --0 | --0 |
| -Less:Other special charges | ---- | ---- | ---- | --45.57M | --0 | ---- | --45.57M | ---- | ---- | ---- |
| -Gain on sale of business | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- |
| Income before tax | 27.61%-40.19M | 11.52%-88.01M | 116.74%10.18M | -25.12%-276.89M | -25.87%-61.07M | -6.16%-55.51M | -57.79%-99.47M | -5.90%-60.84M | -34.48%-221.3M | -0.87%-48.52M |
| Income tax | -187.10%-27K | 143.97%266K | 32.41%143K | -28.14%-601K | 62.50%-135K | 119.50%31K | -3,658.82%-605K | 227.27%108K | -57.91%-469K | -326.42%-360K |
| Earnings from equity interest net of tax | --0 | --0 | --0 | 1.65%-16.01M | --0 | --0 | -156.73%-13.7M | -31.92%-2.31M | -789.24%-16.28M | -272.58%-6.82M |
| Net income | 27.70%-40.16M | 21.58%-88.28M | 115.87%10.04M | -23.28%-292.31M | -10.83%-60.94M | -1.91%-55.54M | -64.59%-112.56M | -6.79%-63.26M | -42.76%-237.11M | -9.76%-54.98M |
| Net income continuous Operations | 27.70%-40.16M | 21.58%-88.28M | 115.87%10.04M | -23.28%-292.31M | -10.83%-60.94M | -1.91%-55.54M | -64.59%-112.56M | -6.79%-63.26M | -42.76%-237.11M | -9.76%-54.98M |
| Minority interest income | 0 | 0 | 34.88%-28K | 62.87%-114K | -69.23%-22K | 87.88%-12K | -5.71%-37K | 73.13%-43K | 95.83%-307K | 63.89%-13K |
| Net income attributable to the parent company | 27.68%-40.16M | 21.55%-88.28M | 115.93%10.07M | -23.39%-292.19M | -10.82%-60.92M | -2.07%-55.53M | -64.62%-112.53M | -7.01%-63.22M | -49.19%-236.81M | -9.81%-54.97M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 27.68%-40.16M | 21.55%-88.28M | 115.93%10.07M | -23.39%-292.19M | -10.82%-60.92M | -2.07%-55.53M | -64.62%-112.53M | -7.01%-63.22M | -49.19%-236.81M | -9.81%-54.97M |
| Basic earnings per share | 29.11%-0.56 | 32.97%-1.24 | 113.08%0.14 | 0.22%-4.47 | 9.78%-0.83 | 17.71%-0.79 | -38.06%-1.85 | 18.32%-1.07 | -20.43%-4.48 | 17.12%-0.92 |
| Diluted earnings per share | 29.11%-0.56 | 32.97%-1.24 | 113.08%0.14 | 0.22%-4.47 | 9.78%-0.83 | 17.71%-0.79 | -38.06%-1.85 | 18.32%-1.07 | -20.43%-4.48 | 17.12%-0.92 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.